RTC-30

RTC-30 is an optimized phenothiazine with anti-cancer potency. RTC-30 contains a hydroxylated linker (N) that confers increased oral bioavailability[1].

Product Specifications

CAS Number

[1423077-95-5]

UNSPSC

12352005

Target

Others

Type

Reference compound

Related Pathways

Others

Applications

Neuroscience-Neuromodulation

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/rtc-30.html

Concentration

10mM

Purity

99.13

Solubility

DMSO : 15 mg/mL (ultrasonic)

Smiles

O=S(C1=CC=C(OC(F)(F)F)C=C1)(NC[C@H](O)CN2C3=CC=CC=C3CCC4=CC=CC=C42)=O

Molecular Formula

C24H23F3N2O4S

Molecular Weight

492.51

References & Citations

[1]Kastrinsky DB, et al. Reengineered tricyclic anti-cancer agents. Bioorg Med Chem. 2015 Oct 1;23 (19) :6528-34.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

bsm-4713M-BF555 100 µL

Beta-Amyloid (1-42) Monoclonal Antibody, AbBy Fluor™ 555 Conjugated

Ask

View Details

MBS8410907-01 0.02 mg

Human EEPD1 Protein Lysate

Ask

View Details

MBS8410907-02 5x 0.02 mg

Human EEPD1 Protein Lysate

Ask

View Details

MR208754L3 10 µg

Slc22a13 (NM_133980) Mouse Tagged Lenti ORF Clone

Ask

View Details

ET1701-90 100 µL

PTP1B Recombinant Rabbit Monoclonal Antibody [JJ0935]

Ask

View Details

P525850 100 µg

IL21R Protein (C-human IgG1-Fc, Human)

Ask

View Details